Logo image of CLW

CLEARWATER PAPER CORP (CLW) Stock Fundamental Analysis

NYSE:CLW - New York Stock Exchange, Inc. - US18538R1032 - Common Stock - Currency: USD

29.93  -0.09 (-0.3%)

After market: 29.93 0 (0%)

Fundamental Rating

3

Taking everything into account, CLW scores 3 out of 10 in our fundamental rating. CLW was compared to 9 industry peers in the Paper & Forest Products industry. Both the profitability and the financial health of CLW get a neutral evaluation. Nothing too spectacular is happening here. CLW is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

CLW had negative earnings in the past year.
In the past year CLW had a positive cash flow from operations.
Of the past 5 years CLW 4 years were profitable.
Each year in the past 5 years CLW had a positive operating cash flow.
CLW Yearly Net Income VS EBIT VS OCF VS FCFCLW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

CLW's Return On Assets of 11.63% is amongst the best of the industry. CLW outperforms 88.89% of its industry peers.
CLW has a better Return On Equity (22.71%) than 77.78% of its industry peers.
Industry RankSector Rank
ROA 11.63%
ROE 22.71%
ROIC N/A
ROA(3y)6.94%
ROA(5y)4.69%
ROE(3y)15.7%
ROE(5y)11.28%
ROIC(3y)N/A
ROIC(5y)N/A
CLW Yearly ROA, ROE, ROICCLW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

With an excellent Profit Margin value of 10.78%, CLW belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
The Gross Margin of CLW (6.40%) is worse than 88.89% of its industry peers.
In the last couple of years the Gross Margin of CLW has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 10.78%
GM 6.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.87%
GM growth 5Y-10.05%
CLW Yearly Profit, Operating, Gross MarginsCLW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

4

2. Health

2.1 Basic Checks

CLW does not have a ROIC to compare to the WACC, probably because it is not profitable.
CLW has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLW has less shares outstanding
Compared to 1 year ago, CLW has an improved debt to assets ratio.
CLW Yearly Shares OutstandingCLW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CLW Yearly Total Debt VS Total AssetsCLW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

CLW has an Altman-Z score of 2.27. This is not the best score and indicates that CLW is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.27, CLW is doing good in the industry, outperforming 66.67% of the companies in the same industry.
A Debt/Equity ratio of 0.34 indicates that CLW is not too dependend on debt financing.
CLW has a better Debt to Equity ratio (0.34) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 2.27
ROIC/WACCN/A
WACC9.66%
CLW Yearly LT Debt VS Equity VS FCFCLW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

CLW has a Current Ratio of 1.66. This is a normal value and indicates that CLW is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.66, CLW is in line with its industry, outperforming 44.44% of the companies in the same industry.
A Quick Ratio of 0.80 indicates that CLW may have some problems paying its short term obligations.
CLW's Quick ratio of 0.80 is on the low side compared to the rest of the industry. CLW is outperformed by 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 0.8
CLW Yearly Current Assets VS Current LiabilitesCLW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

2

3. Growth

3.1 Past

CLW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -102.53%.
CLW shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 72.63% yearly.
The Revenue for CLW has decreased by -14.21% in the past year. This is quite bad
The Revenue has been decreasing by -4.71% on average over the past years.
EPS 1Y (TTM)-102.53%
EPS 3Y-2.41%
EPS 5Y72.63%
EPS Q2Q%-76.22%
Revenue 1Y (TTM)-14.21%
Revenue growth 3Y-7.93%
Revenue growth 5Y-4.71%
Sales Q2Q%-23.78%

3.2 Future

The Earnings Per Share is expected to grow by 79.35% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -9.16% on average over the next years.
EPS Next Y29.54%
EPS Next 2Y79.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-18.65%
Revenue Next 2Y-9.16%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLW Yearly Revenue VS EstimatesCLW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
CLW Yearly EPS VS EstimatesCLW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4 6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLW. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 10.11, which indicates a very decent valuation of CLW.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLW indicates a somewhat cheap valuation: CLW is cheaper than 66.67% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.76. CLW is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 10.11
CLW Price Earnings VS Forward Price EarningsCLW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLW is valued a bit more expensive than the industry average as 77.78% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.52
CLW Per share dataCLW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLW's earnings are expected to grow with 79.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y79.35%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEARWATER PAPER CORP

NYSE:CLW (7/11/2025, 8:04:00 PM)

After market: 29.93 0 (0%)

29.93

-0.09 (-0.3%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)08-05 2025-08-05
Inst Owners85.54%
Inst Owner Change0%
Ins Owners3.07%
Ins Owner Change13.72%
Market Cap486.66M
Analysts80
Price Target37.74 (26.09%)
Short Float %3.26%
Short Ratio2.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-12%
Min EPS beat(2)-122.02%
Max EPS beat(2)98.02%
EPS beat(4)2
Avg EPS beat(4)-36.03%
Min EPS beat(4)-139.6%
Max EPS beat(4)98.02%
EPS beat(8)5
Avg EPS beat(8)-7.16%
EPS beat(12)6
Avg EPS beat(12)-22.93%
EPS beat(16)10
Avg EPS beat(16)-13.19%
Revenue beat(2)1
Avg Revenue beat(2)-1.09%
Min Revenue beat(2)-3.24%
Max Revenue beat(2)1.06%
Revenue beat(4)2
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-3.24%
Max Revenue beat(4)2.5%
Revenue beat(8)4
Avg Revenue beat(8)-0.28%
Revenue beat(12)6
Avg Revenue beat(12)-0.19%
Revenue beat(16)9
Avg Revenue beat(16)0.09%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)108.57%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.11
P/S 0.28
P/FCF N/A
P/OCF 135.18
P/B 0.58
P/tB 0.62
EV/EBITDA 11.52
EPS(TTM)-0.17
EYN/A
EPS(NY)2.96
Fwd EY9.89%
FCF(TTM)-7.82
FCFYN/A
OCF(TTM)0.22
OCFY0.74%
SpS108.35
BVpS51.45
TBVpS48.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.63%
ROE 22.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 10.78%
GM 6.4%
FCFM N/A
ROA(3y)6.94%
ROA(5y)4.69%
ROE(3y)15.7%
ROE(5y)11.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.87%
GM growth 5Y-10.05%
F-Score5
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 4.48
Cap/Depr 132.66%
Cap/Sales 7.42%
Interest Coverage N/A
Cash Conversion 5.72%
Profit Quality N/A
Current Ratio 1.66
Quick Ratio 0.8
Altman-Z 2.27
F-Score5
WACC9.66%
ROIC/WACCN/A
Cap/Depr(3y)74.67%
Cap/Depr(5y)59.25%
Cap/Sales(3y)5.91%
Cap/Sales(5y)4.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-102.53%
EPS 3Y-2.41%
EPS 5Y72.63%
EPS Q2Q%-76.22%
EPS Next Y29.54%
EPS Next 2Y79.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.21%
Revenue growth 3Y-7.93%
Revenue growth 5Y-4.71%
Sales Q2Q%-23.78%
Revenue Next Year-18.65%
Revenue Next 2Y-9.16%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-120.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year965.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-340%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-96.4%
OCF growth 3Y-13.96%
OCF growth 5Y2%